| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |